Sitemap
- Home
-
Science
-
CNS
- NICE Epilepsy Guidelines 2021: Diagnosis and Investigations
- NICE Guidelines 2021: Epilepsy Treatment Protocols
- Differentiating Depression from Bipolar Disorder
- Deep Brain Stimulation and Electromagnetic Interference
- Nice Guideline Algorithm: Epilepsy Care For Children
- A recent head-to head trial comparing the effectiveness of valproate versus levetiracetam
- EEG Cases - Idiopathic Generalized Epilepsy
- EEG Cases - Focal Epilepsy From the Left Hemisphere
- Understanding frequency and types of Electrocardiogram(EKG) abnormalities during routine Electroencephalogram (EEG)*
- AI Based, Personalized Epilepsy Management
- EPILEPSIES: DIAGNOSIS & MANAGEMENT
- Epileptic seizure detection using machine learning classifiers
- Management of anxiety in PWE
- Valproic acid and psychiatric co-morbidities
- Old still stands strong
- The broad Spectrum and Widely used AED
-
Diabetes
- International Diabetes Management Practices Study (IDMPS)
- BE-SMART: An Indian DELPHI Expert Opinion on Insulin Initiaition
- BESMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy)
- AACE/ACE guidelines on insulin initiation 2020
- American Diabetes Association guidelines on insulin initiation 2021
- LANDMARC Study - EASD 2020
- Fasting during Ramadan in patients with diabetes
- Insulin initiation and titration during COVID 19
- Fix Fasting First
- Improving Adherence to Insulin
- Intensification with Basal Insulin
- Basal or premix insulin?
- Management of Hypoglycemia
- Timely Insulinization
- LANDMARC study – 1 year follow-up results
- One-year follow-up results of LANDMARC study – disclosed at ADA 2021
- RSSDI update 2021
- IDF'21 Quick Read: Patient Challenges & Treatments in T2DM
- IDF'21-Quick Read: Expert Views & Opinions in T2DM
- IDF'21 Quick Read: Clinical Pearls for Your Diabetes Practice
- Is there a need of glycemic marker beyond HbA1c?
- It’s time for change, Its Time in Range!
- Top 10 reads: Link between stress and Diabetes
- New technologies in diabetes care and management: Dr. Vijay Viswanathan
- New technologies in diabetes care and management: Dr. Jothydev Kesavadev
- New technologies in diabetes care and management: Dr. Kalyan Kumar Gangopadhyay
- New technologies in diabetes care and management: Dr. Sunil M Jain
- Implications of TIR on physician perception and practices
- Time-in-range and outcomes beyond glycemic control
- Presenting diabetes RWE patient profile insights - Volume 1
- Making strides: The clinical value of time in range – Tadej Battelino
- Implications on clinical practice
-
Kidney Transplant
- Recent advances in induction immunosuppression: Part 1: Dr. E. Steve Woodle
- Infections after transplant: Dr. Subramanian Swaminathan
- Induction Immunosuppression for better outcomes in renal transplantation: Current updates: Part 1: Dr. Daniel C. Brennan
- Induction Immunosuppression for better outcomes in renal transplantation: Current updates: Part 2: Dr. Daniel C. Brennan
- NOTTO Guidelines for Transplant Recipients on COVID‑19 Vaccination
- Antibody response of solid organ transplant recipients after 2-dose of SARS-CoV-2 mRNA vaccine
- Algorithms, AI, and machine learning: New horizons for predicting long-term outcomes: Presented at the ESOT 2021 congress
- Minimizing allograft rejection in renal transplantation
- Early steroid withdrawal protocols
- Today’s challenges for improving graft survival - Presented at the ESOT 2021 congress
- Management strategies and outcomes in renal transplant recipients recovering from COVID-19: A retrospective, multicentre, cohort study
- Relevance of donor specific antibody monitoring after kidney transplantation
- COVID-19 pandemic research opportunities in India
- Post transplant infections and its management: Dr. Umapati N. Hedge
- Antibody mediated rejection - Diagnosis and management: Dr. (Prof.) Dinesh Khullar
-
Otolaryngeal Disorders
- Auricle Schwannoma: Presentation of a rare case and review of existing literature
- Future considerations and directions for thermal ablative technologies
- Vasometer rhinitis: A form of neurogenic non-allergic rhinitis
- Latest abstracts in respiratory medicine - January 2022
- Otolaryngology scanner: January 2022
- Chronic suppurative otitis media
- Evaluation and management of nasal valve collapse - An update
- Tuberculosis otitis media in a patient with multiple cerebral tuberculomas: A case report
- Latest abstracts in respiratory medicine - February 2022
- Otolaryngology scanner - February 2022
-
Respiratory Diseases
- Endobronchial lung volume reduction therapies
- Shrinking lung syndrome caused by systemic lupus erythematosus: A case report
- Cellular and biochemical pathogenic processes in severe influenza virus infection: How does cytokine storm play a role?
- Pulmonoscope: January 2022
- Pulmonology scanner: January 2022
- Targeting molecular and cellular mechanisms in steroid-resistant asthma
- Effects of medication use on small airway function and airway inflammation in patients with clinically controlled asthma
- Not all abolished lung sliding are pneumothorax: The case of a particular lung atelectasis
- Pulmonoscope - February 2022
- Pulmonology scanner - February 2022
- Cutting-Edge Science
-
-
2021
-
Podcast
- Decoding the VTE enigma: Learnings from COVID 19. Episode 2: Dr. Abhay Bhave and Prof. Roopen Arya
- Decoding the VTE enigma: Learnings from COVID 19. Episode 1: Dr. Abhay Bhave and Prof. Roopen Arya
- VTE prevention in surgical settings: A top priority in clinicians checklist. Episode 1 - Dr. Abhay Bhave and Prof. Juan Arcelus
- VTE prevention in surgical settings: A top priority in clinicians checklist. Episode 2 - Dr. Abhay Bhave and Prof. Juan Arcelus
- Decoding the VTE enigma: Learnings from COVID 19. Episode 3: Dr. Abhay Bhave and Prof. Roopen Arya
- VTE prevention in surgical settings: A top priority in clinicians checklist. Episode 3 - Dr. Abhay Bhave and Prof. Juan Arcelus
- VTE prevention in surgical settings: A top priority in clinicians checklist. Episode 4 - Dr. Abhay Bhave and Prof. Juan Arcelus
-
Article
- 1st largest study of kidney transplantation in COVID-19 survivors
- Evaluation of kidney allograft rejection management practices in USA
- Thromboprophylaxis in surgical patients
- Thromboprophylaxis in cancer patients
- Thromboprophylaxis in hospitalized medically ill patients
- RISE Registry Abstract Presented at 58th ERA-EDTA Congress, June 5-8, 2021
- Anticoagulation in COVID-19: Mayo
- Risk factors for VTE in medically ill
- Rentsch newsletter - anticoagulation and mortality in COVID
- Implementing thromboprophylaxis in medically ill
- Garfield ASIA VTE study
- CHEST webinar: COVID-19 and VTE: Key takeaways
- Recent updates in the management of thromboembolism: Newsletter
- COVID-19 & VTE
- MediBYTES December 2021- Recent updates in the management of thromboembolism
- MediBYTES January 2022 - Recent updates in the management of thromboembolism
- MediBYTES February 2022 - Recent updates in the management of thromboembolism
- VTE in surgery
- Implementing thromboprophylaxis in patients with cancer
-
Video
- Kidney transplantation from COVID recovered donors
- Kidney transplantation from COVID recovered recipients
- Management of kidney transplantation: Evolving evidence and strategies: Part 3 - Tolerance protocols
- Management of kidney transplantation: Evolving evidence and strategies: Part 2 - Subclinical rejection
- Management of kidney transplantation: Evolving evidence and strategies: Part 1 - COVID update and vaccination
- rATG as induction therapy in renal transplantation: Indian clinical experience from RISE registry
- VTE prophylaxis in surgical patient population: Dr. David Jimenez, Dr. Suviraj John, Dr. V. Balaji
- Cancer-associated thrombosis (CAT): Updates and recommendations - Dr. Lisa K. Moores, Dr. Mammen Chandy, Dr. Abhay A. Bhave
- VTE prophylaxis in medically-ill hospitalized settings: Dr. Tobias Tritschler, Dr. S. K. Todi, Dr. Ravindra M. Mehta
- The role of thromboprophylaxis for the prevention of VTE: Prof. Gregoire Le Gal
- Primary VTE prophylaxis in patients with cancer undergoing major abdominal/pelvic surgery: Prof. Juan Arcelus
- Prophylactic strategies for VTE in gynecological cancer surgeries
- VTE risk assessment in surgical patients: Prof. Joseph A Caprini
- CHEST webinar: COVID-19 and VTE: From observations to guidelines to changing clinical practices: Do we still know enough?
- VTE in surgery: From risk assessment to appropriate thromboprophylaxis - Dr. David Jimenez, Dr. Vinay K. Kapoor, Dr. Shailesh V. Shrikhande
-
Podcast
-
- Are we oblivious to the second leading cause of mortality in cancer. Episode 1: Dr. Abhay Bhave and Lt. Gen (Dr) Velu Nair (Retd)
- Are we oblivious to the second leading cause of mortality in cancer. Episode 2: Dr. Abhay Bhave and Lt. Gen (Dr) Velu Nair (Retd)
- 3 T approach for PE management
- PE case reports
- Implementing thromboprophylaxis in surgical patients
- 3 T approach for PE management: Dr. Janine Vintch, Dr. Prachee Sathe, Dr. Ravindra Mehta
- Are we oblivious to the second leading cause of mortality in cancer? Episode 3: Dr. Abhay Bhave and Lt. Gen (Dr) Velu Nair (Retd)
-
2021
- Thrombosis
-
CNS
-
Patient Support
-
Patient Support
-
2021
- Article
-
Video
- 10 things to remember while visiting the doctor during COVID-19
- Steps to administer Toujeo® with TouStar® pen
- Steps to administer Toujeo® with SoloStar® pen
- Steps to administer Lantus® with SoloStar® pen
- Steps to administer Lantus® with AllStar® pen
- Exercises to help manage blood glucose
- Sample meal plan for people with diabetes
- Managing diabetes during festivals
- Managing diabetes at workplace
- Managing diabetes at home
- Self-monitoring blood glucose level
- Managing Hypoglycemia and Hyperglycemia
- Traveling with insulins
- How should insulin pen be stored?
- Importance of injection site rotation
- Kidney transplantation patient education (English)
- Kidney transplantation patient education (Hindi)
-
- Pulses - A smart way to safely control blood glucose levels
- Smart exercises to stay fit and safely keep diabetes in check
- Smart recipes to safely manage sweet cravings
- Smart tips for safe hypoglycemic control
- Smart ways to safely boost the immune system
- Smart ways to safely enjoy the mango season
- Smart winter foods to safely manage diabetes
- Smartly fight belly fat to safely control sugar
- SAFE and SMART tips for people with diabetes to start their exercise routine
- Guidance for diabetes management
- SAFE and SMART tips for newly diagnosed people with diabetes
- Smart ways to safely enjoy the Christmas and New Year festivities
- Smart ways to safely manage diabetes during Christmas
- Smart ways to enjoy Suhoor safely and stay healthy
- Enjoy a safe and healthy Iftar with smart tips
- Smart ways to prevent hypoglycemia and safely celebrate Ramadan
- Smart tips to enjoy a safe, healthy and happy Ganesh Chaturthi
- Smart diet choices to enjoy a safe and healthy festive season
- Smart dietary advice to enjoy a safe Navaratri
- Smart tips to satisfy monsoon cravings safely
- A smart guide to manage stress caused by diabetes
-
2021
- Patient Support Articles/Videos
- CNS
- Diabetes
- Kidney Transplant
- Otolaryngeal Disorders
- Respiratory Diseases
-
Patient Support
-
Products
-
Allegra® Group
- Allegra®: Innovative solutions because we truly care
- Allegra® nasal spray: Key features
- Allegra®-M: Only bioequivalent bilayered fexofenadine - montelukast combination published in IJPS
- Reasons to choose Allegra® nasal spray over traditional nasal sprays
- Efficacy and safety of fexofenadine in alleviating pollution aggravated allergic rhinitis
- Evidence for bioequivalent-bilayered Allegra®-M leading to improved treatment and compliance
- Review of sensory attributes and patient preferences of Allegra® nasal spray compared with other INCs
- Allegra®-120
- Allegra®-180
- Allegra®-M
- Allegra® Nasal Duo
- Allegra® Nasal
- Allegra® Suspension
- Allegra Products
- Amaryl® & Combinations
-
Apidra®
- Benefits of Apidra® over Regular Human Insulin (RHI)
- Apidra® - Better PPG control in hospitalized patients
- Apidra® for faster and better PPG control
- New real-world evidence on benefits of changing meal-time insulin therapy to insulin glulisine
- Apidra® - Flexibility benefit to patients, with better PPG control
- The only zinc-free formulation in rapid-acting insulin analogs
- Apidra® - Faster onset and flexible dosing window for better PPG control
- Differential benefits of Apidra in obese patients
- Basal bolus therapy with Lantus® and Apidra® provides more physiological insulin response over twice daily premix
- Basal plus therapy Lantus® and Apidra® provides lesser nocturnal hypoglycemia over twice daily premix therapy
- Superior glycemic control with basal bolus therapy
- More patients reached target A1c on basal plus insulin therapy
- Insulin glulisine injection: Apidra® and Apidra® Solostar®
- Cutting-Edge Apidra
- Cardace®
- Clexane®
- Frisium®
-
Lantus®
- Lantus®: Safer and convenient vs. human premix insulin
- 6 unique reasons to choose basal insulin during COVID-19 pandemic
- Lantus® + OADs: More effective for glycemic control vs. human premix insulin
- Latest real-world evidence from India presented at EASD 2020: LANDMARC
- 5 unique reasons to choose Lantus® over biosimilars during COVID 19 pandemic.
- Fix fasting first: Two decades of evidence of optimal glycemic control with Lantus®
- Which insulin to choose while initiating T2DM patients during COVID-19 challenging time?
- Lantus®: The optimal insulin during COVID-19 pandemic
- Why should Lantus® be the No. 1 choice of insulin?
- Achieving adequate glycemic control during lockdown with basal insulin
- Insulin glargine injection I.P: Lantus® SoloStar and Lantus®
- Steps to administer Lantus® with SoloStar pen
- Steps to administer Lantus® with AllStar pen
- Cutting-Edge Lantus
- Synvisc-One™
- Targocid®
- Thymoglobuline®
-
Toujeo®
- Patient-friendly, reusable Toustar® pen
- Patient-friendly, disposable Solostar® pen
- Toujeo® dose calculation - Initiation and titration
- Toujeo® offers dosing flexibility
- Evidences on Toujeo® vs. Gla-100 on hypoglycemia
- 6 simple steps to use TouStar® pen
- Advantages of Toujeo® in patients with diabetes during Ramadan fast
- Toujeo® Monograph
- Glycemic variability of Toujeo® vs. Gla-100
- Glycemic variability of Toujeo® vs. IDeg-100
- Mechanism Of Action - Toujeo®
- Glycemic variability - Toujeo®
- Insulin glargine injection Toujeo® Solostar®
- Time-in-range: The new glycemic marker
- ATOS: Real-world evidence
- Cutting-Edge Toujeo
- Valparin®
- Vinlep™
- Vinlep™ Suspension
-
Allegra® Group
- Registration
- Login
- My Account
- Search
- Sitemap
- Why Register